These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 35571866)

  • 1. Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease.
    Feng Y; Cheng X; Wu S; Mani Saravanan K; Liu W
    Struct Chem; 2022; 33(5):1503-1515. PubMed ID: 35571866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapy.
    Manandhar S; Pai KSR; Krishnamurthy PT; Kiran AVVVR; Kumari GK
    Struct Chem; 2022; 33(5):1609-1617. PubMed ID: 35754942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target.
    DurdaĞi S
    Turk J Biol; 2020; 44(3):185-191. PubMed ID: 32595355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine.
    Prasad K; Ahamad S; Kanipakam H; Gupta D; Kumar V
    ACS Chem Neurosci; 2021 Mar; 12(5):930-944. PubMed ID: 33606519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages.
    Singh N; Decroly E; Khatib AM; Villoutreix BO
    Eur J Pharm Sci; 2020 Oct; 153():105495. PubMed ID: 32730844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening strategy of TMPRSS2 inhibitors by FRET-based enzymatic activity for TMPRSS2-based cancer and COVID-19 treatment.
    Chen Y; Huang WC; Yang CS; Cheng FJ; Chiu YF; Chen HF; Huynh TK; Huang CF; Chen CH; Wang HC; Hung MC
    Am J Cancer Res; 2021; 11(3):827-836. PubMed ID: 33791156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies.
    Elbadwi FA; Khairy EA; Alsamani FO; Mahadi MA; Abdalrahman SE; Ahmed ZAM; Elsayed I; Ibraheem W; Alzain AA
    Inform Med Unlocked; 2021; 26():100725. PubMed ID: 34514079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting mechanism for SARS-CoV-2
    Zhao X; Luo S; Huang K; Xiong D; Zhang JZH; Duan L
    Nanoscale; 2021 Nov; 13(45):19218-19237. PubMed ID: 34787160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19.
    Esam Z; Akhavan M; Lotfi M; Pourmand S; Bekhradnia A
    Chem Zvesti; 2023; 77(2):1129-1148. PubMed ID: 36312321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational screening combined with well-tempered metadynamics simulations identifies potential TMPRSS2 inhibitors.
    Sharanya CS; Wilbee DS; Sathi SN; Natarajan K
    Sci Rep; 2024 Jul; 14(1):16197. PubMed ID: 39003338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential protease inhibitors and their combinations to block SARS-CoV-2.
    Abhinand CS; Nair AS; Krishnamurthy A; Oommen OV; Sudhakaran PR
    J Biomol Struct Dyn; 2022 Feb; 40(2):903-917. PubMed ID: 32924827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post-translational modification: a multiple target approach.
    Singh R; Gautam A; Chandel S; Sharma V; Ghosh A; Dey D; Roy S; Ravichandiran V; Ghosh D
    In Silico Pharmacol; 2021; 9(1):27. PubMed ID: 33842191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
    Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
    Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Salleh MZ; Deris ZZ
    Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of some dietary flavonoids as potential inhibitors of TMPRSS2 through protein-ligand interaction studies and binding free energy calculations.
    Varughese JK; J K; S SK; Francis D; L JLK; G AT
    Struct Chem; 2022; 33(5):1489-1502. PubMed ID: 35645548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel TMPRSS2 inhibitors for COVID-19 using
    Alzain AA; Elbadwi FA; Alsamani FO
    Inform Med Unlocked; 2022; 29():100870. PubMed ID: 35128036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19.
    Hu X; Shrimp JH; Guo H; Xu M; Chen CZ; Zhu W; Zakharov AV; Jain S; Shinn P; Simeonov A; Hall MD; Shen M
    ACS Pharmacol Transl Sci; 2021 Jun; 4(3):1124-1135. PubMed ID: 34136758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease.
    Wang SC; Chen Y; Wang YC; Wang WJ; Yang CS; Tsai CL; Hou MH; Chen HF; Shen YC; Hung MC
    Am J Cancer Res; 2020; 10(12):4538-4546. PubMed ID: 33415017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.